BRPI0810530A2 - Selante tecidual polimérico - Google Patents

Selante tecidual polimérico

Info

Publication number
BRPI0810530A2
BRPI0810530A2 BRPI0810530-8A2A BRPI0810530A BRPI0810530A2 BR PI0810530 A2 BRPI0810530 A2 BR PI0810530A2 BR PI0810530 A BRPI0810530 A BR PI0810530A BR PI0810530 A2 BRPI0810530 A2 BR PI0810530A2
Authority
BR
Brazil
Prior art keywords
biomaterials
precursor molecule
tissue sealant
polymeric tissue
group
Prior art date
Application number
BRPI0810530-8A2A
Other languages
English (en)
Inventor
Annemie Rehor
Simona Cerritelli
Original Assignee
Kuros Biosurgery Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuros Biosurgery Ag filed Critical Kuros Biosurgery Ag
Publication of BRPI0810530A2 publication Critical patent/BRPI0810530A2/pt
Publication of BRPI0810530B1 publication Critical patent/BRPI0810530B1/pt
Publication of BRPI0810530B8 publication Critical patent/BRPI0810530B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3322—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C08G65/33303—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
    • C08G65/33306—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3342—Polymers modified by chemical after-treatment with organic compounds containing sulfur having sulfur bound to carbon and hydrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58—Ethylene oxide or propylene oxide copolymers, e.g. pluronics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Polyethers (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Surgical Instruments (AREA)
  • Sealing Material Composition (AREA)
  • Medicinal Preparation (AREA)
  • Laminated Bodies (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Details Of Garments (AREA)
BRPI0810530A 2007-04-13 2008-04-14 composição, uso da mesma, biomaterial sintético, seu método de fabricação e kit para formar o mesmo BRPI0810530B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91173707P 2007-04-13 2007-04-13
US60/911,737 2007-04-13
PCT/EP2008/054487 WO2008125655A1 (en) 2007-04-13 2008-04-14 Polymeric tissue sealant

Publications (3)

Publication Number Publication Date
BRPI0810530A2 true BRPI0810530A2 (pt) 2014-10-07
BRPI0810530B1 BRPI0810530B1 (pt) 2018-07-17
BRPI0810530B8 BRPI0810530B8 (pt) 2021-06-22

Family

ID=39671705

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810530A BRPI0810530B8 (pt) 2007-04-13 2008-04-14 composição, uso da mesma, biomaterial sintético, seu método de fabricação e kit para formar o mesmo

Country Status (14)

Country Link
US (2) US8961947B2 (pt)
EP (2) EP2537539B1 (pt)
JP (2) JP2010523243A (pt)
CN (1) CN101711168B (pt)
AT (1) ATE543520T1 (pt)
BR (1) BRPI0810530B8 (pt)
CA (1) CA2685807C (pt)
DK (1) DK2136850T3 (pt)
ES (2) ES2381639T3 (pt)
MX (1) MX2009011005A (pt)
PL (1) PL2136850T3 (pt)
PT (1) PT2136850E (pt)
RU (1) RU2453340C2 (pt)
WO (1) WO2008125655A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008133918A1 (en) * 2007-04-24 2008-11-06 Rutgers, The State University Of New Jersey Dressing compositions and methods
ES2549000T3 (es) 2009-07-27 2015-10-22 Endologix, Inc. Endoprótesis
KR20120089843A (ko) 2009-07-31 2012-08-14 사노피-아벤티스 도이칠란트 게엠베하 인슐린 링커 접합체를 포함한 프로드럭
DK2459171T3 (en) 2009-07-31 2017-09-25 Sanofi Aventis Deutschland Long-acting insulin composition
LT2459220T (lt) 2009-07-31 2020-12-28 Ascendis Pharma A/S Biologiškai suyrantys vandenyje netirpūs hidrogeliai polietilenglikolio pagrindu
WO2011111067A2 (en) * 2010-03-09 2011-09-15 Council Of Scientific & Industrial Research A biodegradable polymeric hydrogel composition
CA2730598C (en) * 2010-03-16 2018-03-13 Confluent Surgical, Inc. Modulating drug release rate by controlling the kinetics of the ph transition in hydrogels
US9119605B2 (en) 2010-05-06 2015-09-01 Zimmer, Inc. Synthetic polymer adhesives and methods for making, using and delivering the same
WO2011142821A1 (en) 2010-05-12 2011-11-17 St. Jude Medical, Inc. Bioadhesive applicator and methods of sealing tissue punctures using same
EP2438930A1 (en) 2010-09-17 2012-04-11 Sanofi-Aventis Deutschland GmbH Prodrugs comprising an exendin linker conjugate
US20140067082A1 (en) 2012-09-06 2014-03-06 Xinyin Liu Bioresorbable ceramic composition for forming a three dimensional scaffold
JP6271566B2 (ja) 2012-10-11 2018-01-31 アセンディス ファーマ エー／エス ヒドロゲルプロドラッグ
EP2968873A4 (en) * 2013-03-13 2016-10-26 Applied Cardiovascular Solutions Llc METHODS, COMPOSITIONS AND DEVICES FOR THE OCCLUSION OF CAVITIES AND PASSAGES
JP6325821B2 (ja) * 2014-01-08 2018-05-16 株式会社日本触媒 硫黄原子含有多分岐ポリアルキレングリコール系ブロック共重合体
WO2016117569A1 (ja) * 2015-01-20 2016-07-28 国立研究開発法人物質・材料研究機構 外科用シーラント
WO2017103914A1 (en) * 2015-12-17 2017-06-22 Regentis Biomaterials Ltd. Ready for use organic solvent free compositions comprising protein-polymer conjugates and uses thereof
WO2019099935A1 (en) * 2017-11-16 2019-05-23 Maculus Therapeutix Llc Materials and methods for administration to nasal cavity
JP7127888B2 (ja) * 2018-09-05 2022-08-30 国立研究開発法人物質・材料研究機構 癒着防止材
FR3087107A1 (fr) 2018-10-15 2020-04-17 Avent Inc. Compositions, systèmes, kits et méthodes d'ablation neurale
JP7852824B2 (ja) * 2021-01-08 2026-04-28 シラグ・ゲーエムベーハー・インターナショナル 生体吸収性封止粉末
CN121154542B (zh) * 2025-11-24 2026-03-24 山东第一医科大学(山东省医学科学院) 用于负载疏水带正电荷药物的响应型胶束及其制备方法

Family Cites Families (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4008341A (en) * 1968-10-11 1977-02-15 W. R. Grace & Co. Curable liquid polymer compositions
US3908039A (en) * 1973-10-25 1975-09-23 Grace W R & Co Photocurable polyene-polythiol lacquer composition
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
DE3433210C1 (de) * 1984-09-10 1986-06-05 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Mittel zur Fuellung von Knochen- und Zahndefekten,zum Knochenaufbau,fuer Knochenkontaktschichten und fuer Knochen- und Zahnwurzelersatz und Verwendung von Carbonatapatit fuer diesen Zweck
DE3543567A1 (de) * 1985-12-10 1987-06-11 Degussa Verfahren zur herstellung von sulfensaeurechloriden und sulfensaeureestern
US4711903A (en) * 1986-01-31 1987-12-08 G. D. Searle & Co. Phenolic thioethers as inhibitors of 5-lipoxygenase
WO1989000051A1 (en) 1987-07-07 1989-01-12 Cytrx Biopool Ltd. Fibrin-binding compound and method
US5504001A (en) * 1987-11-25 1996-04-02 Zymogenetics, Inc. Hybrid plasminogen activator
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5582862A (en) 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
US5137819A (en) * 1988-07-08 1992-08-11 University Of British Columbia Cellulose binding fusion proteins for immobilization and purification of polypeptides
DE68928532T2 (de) 1988-11-09 1998-05-28 Protein Polymer Tech Inc Funktionelles, durch ein rekombinantes verfahren hergestelltes synthetisches proteinpolymer
US5527856A (en) * 1988-11-21 1996-06-18 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5550187A (en) * 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5475052A (en) * 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5247041A (en) * 1989-02-22 1993-09-21 Toray Industries, Inc. Thiol methacrylate or acrylate resin obtained by polymerizing a thiol methacrylate or acrylate compound
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
US5268305A (en) * 1989-06-15 1993-12-07 Biocircuits Corporation Multi-optical detection system
US5330911A (en) * 1989-09-28 1994-07-19 Board Of Regents, The University Of Texas System Surfaces having desirable cell adhesive effects
US5292362A (en) 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5169764A (en) 1990-08-08 1992-12-08 Regeneron Pharmaceuticals, Inc. Multitrophic and multifunctional chimeric neurotrophic factors, and nucleic acids and plasmids encoding the chimeras
US5529914A (en) * 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
EP0564502B1 (en) 1990-11-27 2002-01-30 The American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6559119B1 (en) * 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
SE9101853D0 (sv) 1991-06-17 1991-06-17 Jonas Wadstroem Improved tissue ashesive
SE470006B (sv) * 1991-09-26 1993-10-25 Corline Systems Ab Nytt konjugat, dess framställning och användning samt substrat preparerat med konjugatet
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
DE69329594T2 (de) * 1992-02-28 2001-05-31 Board Of Regents, The University Of Texas System Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung
US5814603A (en) * 1992-06-12 1998-09-29 Affymax Technologies N.V. Compounds with PTH activity
US5292514A (en) * 1992-06-24 1994-03-08 Minnesota Mining And Manufacturing Company Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
CA2103400C (en) * 1992-11-19 1998-08-25 Andrew T. C. Liu Abrasion resistant dental composition product and process
AU675252B2 (en) * 1992-12-18 1997-01-30 Tremco, Inc. Fast-curing, high strength, two-part sealants using acetoacetate-amine cure chemistry
US5321095A (en) * 1993-02-02 1994-06-14 Enzon, Inc. Azlactone activated polyalkylene oxides
CA2155947C (en) * 1993-02-22 2007-08-21 Mark W. Grinstaff Methods for in vivo delivery of biologics and compositions useful therefor
AU696691C (en) 1993-03-12 2003-09-18 American National Red Cross, The Supplemented and unsupplemented tissue sealants, methods of their production and use
TW303299B (pt) * 1993-07-22 1997-04-21 Lilly Co Eli
US5428014A (en) * 1993-08-13 1995-06-27 Zymogenetics, Inc. Transglutaminase cross-linkable polypeptides and methods relating thereto
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US5773577A (en) * 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5583114A (en) 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
EP0725145A4 (en) 1994-08-23 1997-06-11 Drug Delivery System Inst Ltd PROTEIN MODIFICATION PROCESS
AU717906B2 (en) 1994-12-07 2000-04-06 American National Red Cross, The Supplemented and unsupplemented tissue sealants, methods of their production and use
US5747456A (en) * 1994-12-19 1998-05-05 Beth Israel Deaconess Medical Center Continuous low-dose administration of parathyroid hormone or its agonist
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5693341A (en) 1995-03-16 1997-12-02 Collagen Corporation Affinity bound collagen matrices for the delivery of biologically active agents
US5561982A (en) * 1995-05-02 1996-10-08 Universal Vortex, Inc. Method for energy separation and utilization in a vortex tube which operates with pressure not exceeding atmospheric pressure
DE19624148A1 (de) * 1995-06-22 1997-01-02 Henkel Kgaa Masse zum Kleben, Dichten und Beschichten
JP2000500019A (ja) * 1995-11-16 2000-01-11 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング ストレプトアビジン融合タンパク質経由でのペプチドの生産方法
US7026292B1 (en) * 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US6458889B1 (en) * 1995-12-18 2002-10-01 Cohesion Technologies, Inc. Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use
US6833408B2 (en) 1995-12-18 2004-12-21 Cohesion Technologies, Inc. Methods for tissue repair using adhesive materials
WO1997022371A1 (en) * 1995-12-18 1997-06-26 Collagen Corporation Crosslinked polymer compositions and methods for their use
US5874308A (en) * 1996-01-16 1999-02-23 University Of British Columbia Compositions and methods for modulating cell proliferation using growth factor-polysaccharide binding fusion proteins
CN1215421A (zh) * 1996-04-05 1999-04-28 美国3M公司 可见光可聚合的组合物
US5914182A (en) * 1996-06-03 1999-06-22 Gore Hybrid Technologies, Inc. Materials and methods for the immobilization of bioactive species onto polymeric substrates
US5877153A (en) * 1996-06-11 1999-03-02 Commonwealth Biotechnologies Inc. Heparin-binding peptides
WO1998012274A1 (en) * 1996-09-23 1998-03-26 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US7009034B2 (en) * 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
US6620916B1 (en) 1996-09-26 2003-09-16 Ajinomoto Co., Inc. Modified physiologically active proteins and medicinal compositions containing the same
US6258351B1 (en) * 1996-11-06 2001-07-10 Shearwater Corporation Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
DE59807348D1 (de) * 1997-02-05 2003-04-10 Rolic Ag Zug Photovernetzbare Silanderivate
DE19705963A1 (de) 1997-02-17 1998-08-20 Hoechst Ag Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung
GB2348426B (en) 1997-04-03 2001-06-27 California Inst Of Techn Enzyme-mediated modification of fibrin for tissue engineering
EA200000672A1 (ru) 1997-12-18 2000-12-25 Эли Лилли Энд Компани Кристалический терипаратид
US5958874A (en) * 1998-02-18 1999-09-28 The Research Foundation Of State University Of New York Recombinant fibronectin-based extracellular matrix for wound healing
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
AR033639A1 (es) 1998-08-19 2004-01-07 Lilly Co Eli Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis
US6894022B1 (en) * 1998-08-27 2005-05-17 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7241730B2 (en) * 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
US7601685B2 (en) * 1998-08-27 2009-10-13 Eidgenossische Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US6165486A (en) 1998-11-19 2000-12-26 Carnegie Mellon University Biocompatible compositions and methods of using same
EP1137373A4 (en) 1998-12-04 2004-05-19 Chandrashekhar P Pathak BIOCOMPATIBLE, CROSSLINKED POLYMERS
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
EP2311895B1 (en) * 1999-02-01 2017-04-12 Eidgenössische Technische Hochschule Zürich Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
US6312725B1 (en) * 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
ATE314863T1 (de) 1999-04-22 2006-02-15 Eidgenoess Tech Hochschule Kontrollierte abgabe der wachstumsfaktoren von heparin enthaltenden matrizen
RU2238957C2 (ru) 1999-04-26 2004-10-27 Акцо Нобель Н.В. Композиция, включающая соединения с функциональными меркаптогруппами
KR100345214B1 (ko) * 1999-08-17 2002-07-25 이강춘 생체적합성 고분자가 수식된 펩타이드의 비점막 전달
ES2383122T3 (es) 1999-08-27 2012-06-18 Angiodevice International Gmbh Dispositivo de polímero biocompatible
ATE308570T1 (de) * 2000-01-05 2005-11-15 Novartis Pharma Gmbh Hydrogele
US7758882B2 (en) 2000-01-31 2010-07-20 Indiana University Research And Technology Corporation Composite biomaterial including anisometric calcium phosphate reinforcement particles and related methods
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
CA2426692C (en) * 2000-10-19 2011-01-25 Eidgenossische Technische Hochschule Zurich Block copolymers for multifunctional self-assembled systems
EP1348045B1 (en) 2001-01-03 2007-03-14 Santa Fe Science & Technology, Inc. Stable conjugated polymer electrochromic devices incorporating ionic liquids
MXPA03008498A (es) * 2001-03-20 2005-06-30 Univ Zuerich Procesamiento en dos fases de polimeros termosensibles para uso como biomateriales.
CA2367636C (en) * 2001-04-12 2010-05-04 Lisa Mckerracher Fusion proteins
CA2445239C (en) 2001-04-25 2012-08-21 Eidgenossische Technische Hochschule Zurich Drug delivery matrices to enhance wound healing
HK1080500B (zh) 2001-11-07 2008-01-18 Universität Zürich 用於控制细胞向内生长和组织再生的合成基质
CA2470419A1 (en) 2001-12-18 2003-06-26 Eidgenossisch Technische Hochschule Zurich Growth factor modified protein matrices for tissue engineering
US7247609B2 (en) * 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
ATE541595T1 (de) * 2002-03-22 2012-02-15 Kuros Biosurgery Ag Zusammensetzung für die verstärkung von hartem gewebe
US20040002770A1 (en) * 2002-06-28 2004-01-01 King Richard S. Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
US7208171B2 (en) 2002-10-31 2007-04-24 Northwestern University Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
WO2004060346A2 (en) * 2002-12-30 2004-07-22 Angiotech International Ag Drug delivery from rapid gelling polymer composition
US8013068B2 (en) 2003-01-02 2011-09-06 Rohm And Haas Company Michael addition compositions
CA2516113A1 (en) 2003-02-13 2004-08-26 Synthes (U.S.A.) Injectable bone-replacement mixture
US7273896B2 (en) * 2003-04-10 2007-09-25 Angiotech Pharmaceuticals (Us), Inc. Compositions and methods of using a transient colorant
CN1626549A (zh) * 2003-12-11 2005-06-15 中国人民解放军军事医学科学院基础医学研究所 胸腺五肽的聚乙二醇化衍生物，含有它们的药物组合物及用途
EP1593727B1 (en) 2004-05-03 2008-08-06 Rohm And Haas Company Michael addition compositions
EP1593728B1 (en) * 2004-05-03 2012-05-09 Rohm And Haas Company Michael addition compositions
AU2005318097A1 (en) * 2004-12-22 2006-06-29 Kuros Biosurgery Ag Michael-type addition reaction functionalised peg hydrogels with factor XIIIA incorporated biofactors
WO2006073711A2 (en) * 2005-01-06 2006-07-13 Kuros Biosurgery Ag Use of a matrix comprising a contrast agent in soft tissues
WO2007019461A2 (en) * 2005-08-08 2007-02-15 Angstrom Medica, Inc. Cement products and methods of making and using the same

Also Published As

Publication number Publication date
WO2008125655A1 (en) 2008-10-23
CA2685807A1 (en) 2008-10-23
PL2136850T3 (pl) 2012-07-31
EP2136850B1 (en) 2012-02-01
CN101711168A (zh) 2010-05-19
EP2136850A1 (en) 2009-12-30
BRPI0810530B1 (pt) 2018-07-17
JP2014176736A (ja) 2014-09-25
DK2136850T3 (da) 2012-04-10
JP2010523243A (ja) 2010-07-15
PT2136850E (pt) 2012-04-27
US9180222B2 (en) 2015-11-10
US20080253987A1 (en) 2008-10-16
US8961947B2 (en) 2015-02-24
ATE543520T1 (de) 2012-02-15
ES2733276T3 (es) 2019-11-28
EP2537539B1 (en) 2019-04-03
MX2009011005A (es) 2009-11-02
RU2453340C2 (ru) 2012-06-20
JP5930336B2 (ja) 2016-06-08
EP2537539A1 (en) 2012-12-26
BRPI0810530B8 (pt) 2021-06-22
US20150133579A1 (en) 2015-05-14
CA2685807C (en) 2016-04-12
RU2009141875A (ru) 2011-05-20
ES2381639T3 (es) 2012-05-30
CN101711168B (zh) 2013-05-01

Similar Documents

Publication Publication Date Title
PL2136850T3 (pl) Polimeryczny uszczelniacz tkankowy
WO2007127440A3 (en) Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof
Le Neindre et al. Polythiol copolymers with precise architectures: A platform for functional materials
DE502007003302D1 (de) Feuchtigkeitshärtende zusammensetzungen enthaltend silanfunktionelle polymere mit guter haftung
MY155289A (en) Antireflective coating compositions
TW200613338A (en) Moisture-curable, silane crosslinking compositions
GB0606599D0 (en) Extenders for organosiloxane compositions
ATE526365T1 (de) Vernetzbare saccharid-siloxan-zusammensetzungen und daraus gebildete netzwerke, überzüge und artikel
ATE246202T1 (de) Gcsf konjugate
DE60135784D1 (de) Die viskosität von polyalkylenglykol erhöhende polymere formulierungen
RU2007133512A (ru) Отверждаемая композиция, способ ее получения и применения
DE60229305D1 (de) Luftreinigungsfilter und verfahren zur herstellung desselben
BRPI0607457A2 (pt) composição de polìmero e selante de terminada em silano reticulável feita com o mesmo
ATE361952T1 (de) Festigkeitsoptimierte polymere mit gemischten oxyalkyleneiheiten
ATE519793T1 (de) Sequenzierte polymere, diese enthaltende kosmetische zusammensetzung und kosmetisches behandlungsverfahren
NO20062093L (no) Fuktighetsherdende polyeteruretaner med reaktive silangrupper og deres anvendelse som forseglingsmidler, adhesiver og belegg
ATE525438T1 (de) Flammwidrige flexible thermoplastische zusammensetzung, herstellungsverfahren und gegenstände daraus
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
ATE552286T1 (de) Verfahren zur herstellung von polyethylenglykolverbindungen
ATE490986T1 (de) Polymer, vernetztes polymer, zusammensetzung für ein feststoffpolymer-elektrolyt, feststoffpolymer-elektrolyt und klebstoffzusammensetzung
ATE491475T1 (de) Konjugate enthaltend gm-csf und ein polymer
ATE446979T1 (de) Zusammensetzung mit aziridingruppen und ihre verwendung
BRPI0409522A (pt) composições, processo para a reticulação de uma composição polimérica, processo para a formação de um revestimento reticulado, composições de revestimento, substrato e produto
BR112012007965A2 (pt) composto, e, método para ajustar o ph em uma composição de revestimento e para produzir um composto.
ATE527294T1 (de) Polymeradditive für pulverlacke

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/04/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2875 DE 10-02-2026 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.